Compare Stocks › ABBV vs MSCI

AbbVie Inc. (ABBV) vs MSCI Inc. (MSCI): Which Is the Better Buy in 2026?

As of 2026-11-02, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. MSCI is overvalued at $623, with an intrinsic value of $456 and a margin of safety of -37%. Of the two, MSCI has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
MSCI
MSCI Inc.
$623.38

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
MSCI
  • ★MSCI Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★Gross margin of 82.9% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★MSCI Inc. scores 99/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
MSCI
  • ⚠FCF yield of 2.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.

Key Valuation Metrics

Learn more →
ABBV
MSCI
Valuation
N/A
Free Cash Flow
$1.19B
N/A
FCF Yield
2.62%
50.67
Trailing P/E
32.97
18.24
Forward P/E
27.80
Quality & Moat
29.08%
ROIC
22.20%
N/A
ROE
N/A
73.72%
Gross Margin
82.89%
0.60
PEG Ratio
1.96
Balance Sheet Safety
N/A
Net Debt / Equity
N/A
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
3.29
2.35%
Dividend Yield
1.32%
ABBV: 5Ties: 1MSCI: 2
ABBVMSCI

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MSCI

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MSCI
$2.56
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.95B
Δ Market Cap
+$5.01B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MSCI
36.8% Overvalued
Price is 36.8% above estimated fair value
Current Price: $623.38
Fair Value: $455.80
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

MSCI

What growth rate is the market pricing in at $623?

+17.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +18.4%

The market implies +17.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +18.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
MSCI
99/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MSCI
-2.74
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MSCI
Insiders 3.7%Institutions 97.1%
No. of Institutional Holders1,577
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
MSCI
1
Buys (3M)
5
Buys (12M)
Total value (12M): $15.51M
TANEJA RAJAT
Director
$1.00M
@ $560.00 · 2026-09-02
FERNANDEZ HENRY A
Chief Executive Officer
$2.25M
@ $562.40 · 2026-05-15
ASHE ROBERT GERARD
Director
$2.00M
@ $543.21 · 2026-02-18
FERNANDEZ HENRY A
Chief Executive Officer
$3.56M
@ $523.56 · 2026-02-17
FERNANDEZ HENRY A
Chief Executive Officer
$6.70M
@ $536.14 · 2025-12-05
FERNANDEZ HENRY A
Chief Executive Officer
$6.73M
@ $542.87 · 2025-07-25
FERNANDEZ HENRY A
Chief Executive Officer
$3.04M
@ $574.51 · 2025-02-24
FERNANDEZ HENRY A
Chief Executive Officer
$1.78M
@ $612.80 · 2024-12-05
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MSCI
2
Sells (3M)
7
Sells (12M)
Total value (12M): $8.78M
GUTOWSKI ROBERT J
General Counsel
$1.48M
@ $623.66 · 2026-10-22
WIECHMANN ANDREW CRAIG
Chief Financial Officer
$256,500
@ $570.00 · 2026-10-12
WIECHMANN ANDREW CRAIG
Chief Financial Officer
$272,052
@ $604.56 · 2026-06-10
MUNARI ALVISE J.
Officer
$5.92M
@ $592.04 · 2026-04-24
WIECHMANN ANDREW CRAIG
Chief Financial Officer
$252,000
@ $560.00 · 2026-03-17
WIECHMANN ANDREW CRAIG
Chief Financial Officer
$247,500
@ $550.00 · 2025-12-11
GUTOWSKI ROBERT J
General Counsel
$348,454
@ $558.42 · 2025-11-24
PETTIT CARROLL DOUGLAS BAER
President
$2.82M
@ $563.62 · 2025-06-05
PETTIT CARROLL DOUGLAS BAER
President
$2.76M
@ $552.59 · 2025-05-05
PETTIT CARROLL DOUGLAS BAER
President
$2.62M
@ $524.25 · 2025-04-04
PETTIT CARROLL DOUGLAS BAER
President
$2.84M
@ $568.36 · 2025-03-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MSCI
FearGreed
😏Greed(68/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
MSCI
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
View ABBV Full AnalysisView MSCI Full Analysis

Frequently Asked Questions: ABBV vs MSCI

Is AbbVie Inc. or MSCI Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, MSCI trades at a -36.8% margin of safety (intrinsic value $456 vs. price $623), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or MSCI Inc.?▼

MSCI scores 99/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. MSCI scores 5.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or MSCI Inc.?▼

ABBV earns 29.1% ROIC versus MSCI's 22.2%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or MSCI Inc.'s?▼

MSCI's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). MSCI has raised its dividend for 3 consecutive years.

ABBV vs MSCI: Which Is the Better Buy in 2026? | SafetyMargin.io